These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20429051)

  • 1. Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide.
    Jumpertz R; Wiesner T; Blüher M; Engeli S; Bátkai S; Wirtz H; Bosse-Henck A; Stumvoll M
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):591-5. PubMed ID: 20429051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea.
    Wang X; Yu Q; Yue H; Zhang J; Zeng S; Cui F
    Biomed Res Int; 2016; 2016():9782031. PubMed ID: 26904688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study.
    Drummen M; Tischmann L; Gatta-Cherifi B; Cota D; Matias I; Raben A; Adam T; Westerterp-Plantenga M
    J Clin Endocrinol Metab; 2020 Jul; 105(7):e2511-20. PubMed ID: 32333763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.
    Hill MN; Miller GE; Carrier EJ; Gorzalka BB; Hillard CJ
    Psychoneuroendocrinology; 2009 Sep; 34(8):1257-62. PubMed ID: 19394765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
    Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
    Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
    Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V
    Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry.
    Schreiber D; Harlfinger S; Nolden BM; Gerth CW; Jaehde U; Schömig E; Klosterkötter J; Giuffrida A; Astarita G; Piomelli D; Markus Leweke F
    Anal Biochem; 2007 Feb; 361(2):162-8. PubMed ID: 17196922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants.
    Romero-Sanchiz P; Nogueira-Arjona R; Pastor A; Araos P; Serrano A; Boronat A; Garcia-Marchena N; Mayoral F; Bordallo A; Alen F; Suárez J; de la Torre R; Pavón FJ; Rodríguez de Fonseca F
    Neuropharmacology; 2019 May; 149():212-220. PubMed ID: 30822499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure.
    Jumpertz R; Guijarro A; Pratley RE; Piomelli D; Krakoff J
    J Clin Endocrinol Metab; 2011 Mar; 96(3):787-91. PubMed ID: 21177788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion.
    Little TJ; Cvijanovic N; DiPatrizio NV; Argueta DA; Rayner CK; Feinle-Bisset C; Young RL
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E489-E495. PubMed ID: 29438631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral Endocannabinoids Associated With Energy Expenditure in Native Americans of Southwestern Heritage.
    Heinitz S; Basolo A; Piaggi P; Piomelli D; Jumpertz von Schwartzenberg R; Krakoff J
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1077-1087. PubMed ID: 29300902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabimimetic effects of osteopathic manipulative treatment.
    McPartland JM; Giuffrida A; King J; Skinner E; Scotter J; Musty RE
    J Am Osteopath Assoc; 2005 Jun; 105(6):283-91. PubMed ID: 16118355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry.
    Lam PM; Marczylo TH; Konje JC
    Anal Bioanal Chem; 2010 Nov; 398(5):2089-97. PubMed ID: 20835819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.
    Annuzzi G; Piscitelli F; Di Marino L; Patti L; Giacco R; Costabile G; Bozzetto L; Riccardi G; Verde R; Petrosino S; Rivellese AA; Di Marzo V
    Lipids Health Dis; 2010 Apr; 9():43. PubMed ID: 20426869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
    Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
    Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use.
    Kroll SL; Meier P; Mayo LM; Gertsch J; Quednow BB
    Neuropsychopharmacology; 2024 Sep; 49(10):1630-1639. PubMed ID: 38773316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study.
    Monteleone P; Piscitelli F; Scognamiglio P; Monteleone AM; Canestrelli B; Di Marzo V; Maj M
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E917-24. PubMed ID: 22442280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.